OFIX (Orthofix) Net Profit

Corporate emblem and logo of orthofix.com (OFIX)

The historical price chart for Orthofix Medical Inc. (OFIX) reflects profit dynamics, which currently stand at -0.06. Orthofix Medical Inc. (OFIX) utilizes automated machinery to create complex spinal constructs, while product development and physician training remain the domain of experts. The brand's high authority among surgeons is driven by the reliability of its implants. The modernization of workshops and the upgrading of the CNC fleet ensure stable capacity utilization.

OFIX: Orthofix Medical Inc. Net Profit 07/04/2022 - 10/29/2026

Financial and market metric breakdowns for Orthofix (OFIX)

- current quotes and average value forecast:
Market Chart Orthofix Corp|OFIX - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization Orthofix Corp|OFIX - Total Company Value
- book capitalization data:
Net Assets per Single Share Orthofix|OFIX - Book Capitalization|Market Capitalization to Book Value orthofix.com|OFIX - Cumulative Company Assets
- debt and liquidity details:
Aggregate Debt to Equity Orthofix Medical Inc.|OFIX - Long-Term Debt to Capital|Current Liabilities to Capital Orthofix Medical|OFIX - Company Aggregate Debts|Debt to Book Value Ratio Orthofix Corp|OFIX - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Orthofix|Quick Liquidity Indicator orthofix.com
- earnings and valuation multiples information:
OFIX - Net Profit
Fundamental valuation:Orthofix Corp
Product sample of Orthofix Medical Inc.

Investors seek a balance between fundamental value and the market valuation of assets. This metric captures the daily cash balance remaining after deducting all operating and tax expenses. For Orthofix Medical Inc. (OFIX), this trend reflects the efficiency of high-cost express delivery of sterile implants tailored to surgical schedules. Sharp fluctuations confirm that profits depend on logistical precision. By analyzing the company's net income, one can identify hidden operational failures.

Key competitors

BSX - Net Financial Result|EW (Edwards Lifesciences) - Net Profit|Net Profit resmed.com|Company Net Income Insulet (PODD)|Company Net Income ZBH (Zimmer Biomet Holdings)|Net Profit COO (CooperVision)|Net Financial Result Align Corp (ALGN)|GMED: Net Income|Profit After Tax TMDX|ATEC: Net Profit|Company Net Income CryoLife (AORT)|ENOV (DJO Global) - Net Profit|Company Profit IART (Integra LifeSciences Inc.)|Net Income ESTA (Establishment Labs)|BBNX (betabionics.com) - Final Profit|Company Net Income IRADIMED IRMD|EMBC - Net Income|Tandem Diabetes - Net Profit|Company Net Income Axogen Surgical|SIBN: Net Profit|Company Profit BVS|KIDS (OrthoPediatrics Corp) - Net Profit|Treace Medical Concepts Inc (TMCI) - Net Financial Result|Net Profit SRTA|Net Income Carlsmed Medical CARL|Net Profit RXST (RxSight, Inc.)|Net Profit ClearPoint Neuro Inc. CLPT|STXS - Company Net Income|STIM: Company Net Income|SGHT (Sight Sciences, Inc) - Net Income|Orchestra BioMed Inc. - Final Profit|ANIK (Anika Therapeutics Inc.) - Net Profit|Company Net Income inspiremd.com NSPR|Company Net Income Jin Medical International (ZJYL)|vivani.com (VANI) - Annual Net Income|Xtant Medical - Net Income|Net Profit NeuroOne Medical Technologies Corp. NMTC|Modular Med - Net Profit|Net Financial Result myomo.com MYO|Envoy Medical (COCH) - Company Net Income|Profit After Tax VVOS (Vivos Therapeutics Inc.)|Company Net Income enVVeno|Net Income SINTX Technologies (SINT)|Net Profit TNON|LFWD - Company Net Income|Company Net Income Autonomix Medical AMIX|IVF: Company Profit|BBLG: Net Income|Axonics, Inc - Profit After Payment of Taxes|BIOLASE, Inc. (BIOL) - Company Net Income|Company Net Income Dynatronics (DYNT)|Company Net Income Paragon 28 Inc.|INVO: Final Profit